Novozymes
Provides biological solutions to customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives.
HQ location
Bagsværd, Denmark
Website
Launch date
Employees
Market cap
$28.2b
Enterprise value
$31.2b
Share price
DKK454.10 NZYM-B.CO
Company register number
10007127
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
Novo Nordisk(exited)
| DKK | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 7 % | 17 % | 2 % | 64 % | 7 % | 8 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 35 % | 35 % | 33 % | 36 % | 38 % | 39 % | 40 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 21 % | 21 % | 17 % | 8 % | 17 % | 18 % | 20 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 13 % | 11 % | 11 % | - | - | - | - |
Source: Company filings or news article, Equity research estimates
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Novozymes
Edit
ACQUISITION by The Mosaic Company Feb 2022
ACQUISITION by Novozymes Sep 2016
ACQUISITION by Novozymes Dec 2022
ACQUISITION by Novozymes Jun 2013
ACQUISITION by Novozymes Nov 2012
ACQUISITION by Novozymes Sep 2006
ACQUISITION by Novozymes Nov 2021
